How you use the battery also matters
We use a non-GMO, sunflower-based phospholipid complex to create our liposomes
In 2025, the company reported a modest +0.99% YoY revenue growth, but the underlying story is more interesting: Dupixent ($17.8B) remains the clear growth engine, benefiting from expanding indications like COPD and broader patient reach, while the EYLEA franchise ($7.89B) continues to be a core contributor despite facing biosimilar pressure, supported by the transition to EYLEA HD, and Libtayo ($1.45B) is steadily gaining ground in oncology, particularly in lung cancer settings
SMARCA4, SMARCB1, and PBRM1 are frequently mutated in 10% of patients with non-small lung adenocarcinomas 7 , and in almost patients with rhabdoid tumors, epithelioid sarcomas 8,9 , or in 40% of renal clear cell carcinomas 7
Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in pcos patients: A systematic review and meta-analysis of randomized clinical trials
Just a gentle hey, check in with your stomach a few times a day